Dyne Therapeutics Q3 EPS $(0.83) Up From $(2.01) YoY

Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.83) per share. This is a 58.71 percent increase over losses of $(2.01) per share from the same period last year.

Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.83) per share. This is a 58.71 percent increase over losses of $(2.01) per share from the same period last year.

Total
0
Shares
Related Posts